<DOC>
<DOCNO>EP-0620000</DOCNO> 
<TEXT>
<INVENTION-TITLE>
COSMETIC OR PHARMACEUTICAL USE OF N-ACYLALCANOLAMINES.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K800	A61K800	A61K830	A61K830	A61K834	A61K837	A61K841	A61K842	A61K855	A61K858	A61K867	A61K892	A61K892	A61K3116	A61K3116	A61K3121	A61K31215	A61K3166	A61K3166	A61P1700	A61P1700	A61Q1300	A61Q1300	A61Q1700	A61Q1700	A61Q1702	A61Q1702	A61Q1704	A61Q1704	A61Q1900	A61Q1900	A61Q1908	A61Q1908	C07C23300	C07C23318	C07C23320	C07F900	C07F909	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61P	A61P	A61Q	A61Q	A61Q	A61Q	A61Q	A61Q	A61Q	A61Q	A61Q	A61Q	A61Q	A61Q	C07C	C07C	C07C	C07F	C07F	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K8	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61P17	A61P17	A61Q13	A61Q13	A61Q17	A61Q17	A61Q17	A61Q17	A61Q17	A61Q17	A61Q19	A61Q19	A61Q19	A61Q19	C07C233	C07C233	C07C233	C07F9	C07F9	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The use of at least one N-acyl-alkanolamine deriv. of formula R2-CHR3-(CH2)n-NH-R1 (I) is claimed as active agent in a cosmetic and/or pharmaceutical compsn. for preventing damage to skin by light rays and/or for treating skin damaged by light and/or heat or insect stings. R1 = acyl derived from a satd 1-18C or unsatd. 3-18C carboxylic acid or their derivs.; R2 = OH or ester gp.; R3 = H or 1-4C alkyl; n = 0-5.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
RHONE POULENC RORER GMBH
</APPLICANT-NAME>
<APPLICANT-NAME>
RHONE POULENC RORER GMBH
</APPLICANT-NAME>
<APPLICANT-NAME>
RHONE-POULENC RORER GMBH
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
GEHRING WOLFGANG
</INVENTOR-NAME>
<INVENTOR-NAME>
GHYCZY MIKLOS
</INVENTOR-NAME>
<INVENTOR-NAME>
NISSEN-ZOUFAL BRIGITTE
</INVENTOR-NAME>
<INVENTOR-NAME>
GEHRING, WOLFGANG
</INVENTOR-NAME>
<INVENTOR-NAME>
GHYCZY, MIKLOS
</INVENTOR-NAME>
<INVENTOR-NAME>
NISSEN-ZOUFAL, BRIGITTE
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
